Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]
Phase 2 trial of vismodegib (GDC-0449) in patients with recurrent glioblastoma multiforme that could be surgically removed; the study is com…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma [Phase 2]
Phase 2 trial evaluating Gliadel Wafer with fluorescence-guided surgery using 5-ALA followed by radiation therapy and temozolomide in patien…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]
Phase 2 trial update for dovitinib in adults with recurrent or progressive glioblastoma. The study is completed, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors [Phase 1]
This Phase 1 trial tests the safety of the p28 peptide in younger patients with recurrent or progressive central nervous system tumors and t…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Glioblastoma Platelet Activation Study
This clinical trial update reports that the study on glioblastoma evaluating platelet activation and circulating platelet-monocyte conjugate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial comparing erlotinib with temozolomide or carmustine in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS research · 2017-07-24Clinical Trial Update: Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
This clinical trial update describes using Proteome Profiler Antibody Arrays to identify angiogenesis-related predictors in glioblastoma.
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation [NA]
This is a clinical trial update evaluating simultaneous integrated boost with chemoradiation for glioblastoma. The sponsor is Taichung Veter…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of Trans Sodium Crocetinate in combination with radiation and temozolomide for newly diagnose…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence [Phase 1]
Phase 1 study evaluating bevacizumab delivered into the tumor resection cavity for glioblastoma at first recurrence has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating the combination of temozolomide, thalidomide, and celecoxib after radiation therapy in newly diagnosed glioblastoma…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of veliparib plus temozolomide in patients with recurrent glioblastoma; the t…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Bevacizumab With or Without Surgery for Adult Glioblastomas [Phase 2]
Phase 2 trial evaluating bevacizumab with or without surgery for adult glioblastomas was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients [Phase 3]
This update reports the results of a Phase 3 trial comparing lomustine plus temozolomide versus standard therapy for glioblastoma to evaluat…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma [Phase 2]
Phase II trial of BKM120 in recurrent glioblastoma has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 trial of cilengitide in adults undergoing surgery for recurrent or progressive glioblastoma multiforme was terminated and results we…
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas
This document reports an update on using APT MRI to predict Bevacizumab efficacy in patients with recurrent malignant gliomas; the trial sta…
-
FDA approval · 2017-06-06FDA Approved: GLEOLAN — Original Application (Medexus Pharma, Inc.)
The FDA approved Gleolan (aminolevulinic acid hydrochloride) from Medexus Pharma under NDA208630 for use in fluorescence-guided visualizatio…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma [NA]
A terminated clinical trial evaluating stem cell radiotherapy with temozolomide for newly diagnosed high-grade glioma has posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma [Phase 1]
This Phase 1 study evaluating stereotactic radiosurgery combined with nivolumab and valproate in patients with recurrent glioblastoma has be…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Amgen 386 for Recurrent Glioblastoma [Phase 1, Phase 2]
Clinical trial update reports completion of Amgen's AMG-386 studies in recurrent glioblastoma (Phase 1/2) with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma [Phase 2]
Phase 2 trial of bendamustine hydrochloride in adults with recurrent or progressive anaplastic glioma has completed and results have been po…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner
This clinical trial update describes a study evaluating stress and exercise behavior and survival in patients with newly diagnosed glioblast…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN) [Phase 2]
Phase 2 trial evaluating bevacizumab alone or in combination with irinotecan for glioblastoma has completed.